Boston Scientific (BSX) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Boston Scientific Corporation  (NYSE: BSX)

Boston Scientific Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BSX Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 70.71 % 47.79 % 65.43 % 46.06 %
Gross Margin (Q2 TTM) 69.92 % 47.8 % 66.39 % 46.3 %
Gross Profit Margin 5 Yr. Avg. 68.94 % 53.96 % 64.67 % 47.07 %
EBITDA Margin (Q2 MRQ) 36.33 % 19.99 % 19.59 % 20.57 %
EBITDA Margin (Q2 TTM) 29.07 % 18.9 % 20.86 % 19.07 %
EBITDA Margin 5 Yr. Avg. 23.08 % 17.58 % 31.16 % 22.03 %
Operating Margin (Q2 MRQ) 21.65 % 12.24 % 16.57 % 16.03 %
Operating Margin (Q2 TTM) 19.77 % 11.24 % 17.92 % 16.33 %
Operating Margin 5 Yr. Avg. 14.62 % 10.03 % 14.41 % 17.09 %
Pre-Tax Profit Margin (Q2 MRQ) 19.48 % 10.53 % 10.93 % 13.94 %
Pre-Tax Profit Margin (Q2 TTM) 18.39 % 10.82 % 12.86 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. 12.49 % 8.62 % 10.45 % 12.49 %
Net Margin (Q2 MRQ) 16.63 % 7.84 % 8.14 % 11.41 %
Net Margin (Q2 TTM) 17.47 % 7.58 % 9.99 % 10.76 %
Net Margin 5 Yr. Avg. 10.17 % 7.41 % 6.23 % 9.95 %



Business Segment Profit Margin
 
MedSurg
  Explore MedSurg Segment  -
Cardiovascular
  Explore Cardiovascular Segment  -
Endoscopy
  Explore Endoscopy Segment  -
Urology
  Explore Urology Segment  -
Neuromodulation
  Explore Neuromodulation Segment  -
Watchman
  Explore Watchman Segment  -
Cardiac Rhythm Management
  Explore Cardiac Rhythm Management Segment  -
Electrophysiology
  Explore Electrophysiology Segment  -
Latin America and Canada BSX Reportable Segments
  Explore Latin America and Canada BSX Reportable Segments Segment  -
U S
  Explore U S Segment  -
U S MedSurg
  Explore U S MedSurg Segment  -
U S Cardiovascular
  Explore U S Cardiovascular Segment  -
Endoscopy U S
  Explore Endoscopy U S Segment  -
Urology U S
  Explore Urology U S Segment  -
Neuromodulation U S
  Explore Neuromodulation U S Segment  -
Watchman U S
  Explore Watchman U S Segment  -
Cardiac Rhythm Management U S
  Explore Cardiac Rhythm Management U S Segment  -
Electrophysiology U S
  Explore Electrophysiology U S Segment  -
Int l
  Explore Int l Segment  -
Int l MedSurg
  Explore Int l MedSurg Segment  -
Int l Cardiovascular
  Explore Int l Cardiovascular Segment  -
Endoscopy Int l
  Explore Endoscopy Int l Segment  -
Urology Int l
  Explore Urology Int l Segment  -
Neuromodulation Int l
  Explore Neuromodulation Int l Segment  -
Interventional Cardiology Vascular Therapies
  Explore Interventional Cardiology Vascular Therapies Segment  -
Interventional Cardiology Vascular Therapies U S
  Explore Interventional Cardiology Vascular Therapies U S Segment  -
Interventional Cardiology Vascular Therapies Int l
  Explore Interventional Cardiology Vascular Therapies Int l Segment  -
Watchman Int l
  Explore Watchman Int l Segment  -
Electrophysiology Int l
  Explore Electrophysiology Int l Segment  -
Cardiac Rhythm Management Int l
  Explore Cardiac Rhythm Management Int l Segment  -
Interventional Oncology Embolization
  Explore Interventional Oncology Embolization Segment  -
Interventional Oncology Embolization U S
  Explore Interventional Oncology Embolization U S Segment  -
Interventional Oncology Embolization Int l
  Explore Interventional Oncology Embolization Int l Segment  -
Europe Middle East and Africa BSX Reportable Segments
  Explore Europe Middle East and Africa BSX Reportable Segments Segment  -
Asia-Pacific BSX Reportable Segments
  Explore Asia-Pacific BSX Reportable Segments Segment  -
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q2 MRQ) 23.5 % 0.27 % 0.21 % 1.39 %
Free Cash Flow Margin (Q2 TTM) 17.26 % 12.29 % 13.98 % 9.19 %
Free Cash Flow Margin 5 Yr. Avg. - 10.76 % 15.38 % 14.52 %
Net Cash Flow Margin (Q2 MRQ) 0 % -0.27 % -0.02 % 0.13 %
Net Cash Flow Margin (Q2 TTM) 4.3 % -0.99 % 0.08 % 1.81 %
Net Cash Flow Margin 5 Yr. Avg. - 0.81 % 3.13 % 5.85 %
Effective Tax Rate (Q2 MRQ) 14.62 % 21.94 % 25.41 % 18.83 %
Effective Tax Rate (Q2 TTM) 5 % 25.71 % 22.81 % 19.33 %
Effective Tax Rate 5 Yr. Avg. 19.13 % 18.9 % 20.39 % 19.86 %
Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.